[A study of spontaneous nosebleed. Pharmaceuticals contributed probably in every third case].
Olofsson
K
K
Oron-, näs- och halskliniken, Norrlands Universitetssjukhus, Umeå.
Dahlqvist
A
A
D000328:Adult; D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D000925:Anticoagulants / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects; D001241:Aspirin / Q000009:adverse effects; D004564:Electrocoagulation; D004844:Epistaxis / Q000139:chemically induced* / Q000209:etiology / Q000628:therapy; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D013630:Tampons, Surgical; D014859:Warfarin / Q000009:adverse effects
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000925:Anticoagulants; D000959:Antihypertensive Agents; D014859:Warfarin; D001241:Aspirin
Studie av spontana näsblödningar. Troligt att farmaka bidrog i vart tredje fall.